Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Henry Bern
University College London - MRC Clinical Trials Unit
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
1,598
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against COVID-19: COVAC1, a Phase I, Dose-Ranging Trial
Number of pages: 34
Posted: 16 Jun 2021
Katrina M. Pollock
,
Hannah M. Cheeseman
,
Alexander J. Szubert
,
Vincenzo Libri
,
Marta Boffito
,
David Owen
, Henry Bern,
Jessica O’Hara
,
Leon R. McFarlane
,
Nana-Marie Lemm
,
Paul F. McKay
,
Tommy Rampling
,
Yee Ting N. Yim
,
Ana Milinkovic
,
Cherry Kingsley
,
Tom Cole
,
Susanne Fagerbrink
,
Marites Aban
,
Maniola Tanaka
,
Savviz Mehdipour
,
Alexander Robbins
,
William Budd
,
Saul N. Faust
,
Hana Hassanin
,
Catherine A. Cosgrove
,
Alan Winston
,
Sarah Fidler
,
David T. Dunn
,
Sheena McCormack
and
Robin John Shattock
Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, University College London - MRC Clinical Trials Unit, University College London, Imperial College London, NIHR Imperial Clinical Research Facility, University College London - MRC Clinical Trials Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London, Imperial College London, University College London Hospitals NHS Foundation Trust - Department of Clinical Virology, University College London, Government of the United Kingdom - Chelsea and Westminster Hospital NHS Foundation Trust, Imperial College London, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, NIHR Imperial Clinical Research Facility, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Surrey - Surrey Clinical Research Centre, St George’s University London - St George’s Vaccine Institute, Imperial College London - Department of Infectious Disease, Imperial College London - Section of Virology, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Imperial College London - Department of Infectious Disease
Downloads
1,550
(25,099)
View PDF
Download
Abstract:
2.
COVAC1 Phase 2a Expanded Safety and Immunogenicity Study of a Self-Amplifying RNA Vaccine Against SARS-CoV-2
Number of pages: 33
Posted: 27 Sep 2022
Alexander J. Szubert
,
Katrina M. Pollock
,
Hannah M. Cheeseman
,
Jasmini Alagaratnam
, Henry Bern,
Olivia Bird
,
Marta Boffito
,
Ruth Byrne
,
Tom Cole
,
Catherine A. Cosgrove
,
Saul N. Faust
,
Sarah Fidler
,
Eva Galiza
,
Hana Hassanin
,
Mohini Kalyan
,
Vincenzo Libri
,
Leon R. McFarlane
,
Ana Milinkovic
,
Jessica O’Hara
,
David R. Owen
,
Daniel Owens
,
Mihaela Pacurar
,
Tommy Rampling
,
Simon S. Skene
,
Alan Winston
,
James Woolley
,
Yee Ting N. Yim
,
David T. Dunn
,
Sheena McCormack
and
Robin John Shattock
University College London - MRC Clinical Trials Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, University College London - MRC Clinical Trials Unit, St George’s University London - St George’s Vaccine Institute, Government of the United Kingdom - Department of HIV/GUM, Government of the United Kingdom - Department of HIV/GUM, NIHR Imperial Clinical Research Facility - NIHR Imperial Biomedical Research Centre, St George’s University London - St George’s Vaccine Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Imperial College London - Section of Virology, St George’s University London - St George’s Vaccine Institute, University of Surrey - Surrey Clinical Research Centre, Imperial College London - Department of Infectious Disease, University College London, Imperial College London - Department of Infectious Disease, Chelsea and Westminster Hospital NHS FT, Imperial College London - Department of Infectious Disease, NIHR Imperial Clinical Research Facility - NIHR Imperial Biomedical Research Centre, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton - NIHR Southampton Biomedical Research Centre, University College London - Comprehensive Biomedical Research Centre, University of Surrey - Surrey Clinical Research Centre, Imperial College London - Department of Infectious Disease, University of Surrey - Surrey Clinical Research Centre, University College London - Comprehensive Biomedical Research Centre, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Imperial College London - Department of Infectious Disease
Downloads
48
(803,489)
View PDF
Download
Abstract:
SARS-CoV-2, vaccination, self-amplifying RNA, saRNA, immune response
Feedback